Diazoxide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01119 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 82 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypotrichosis simplex of the scalp | KG + DL |
| 2 | congenital hypotrichosis milia | KG + DL |
| 3 | diffuse alopecia areata | KG + DL |
| 4 | alopecia | KG + DL |
| 5 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 6 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 7 | hypertrichosis (disease) | KG + DL |
| 8 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 9 | isolated genetic hair shaft abnormality | KG + DL |
| 10 | autosomal dominant hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 11 | diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 12 | autosomal recessive hyperinsulinism due to SUR1 deficiency | KG + DL |
| 13 | Smouldering systemic mastocytosis | KG + DL |
| 14 | autosomal recessive hyperinsulinism due to Kir6.2 deficiency | KG + DL |
| 15 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 16 | hyperinsulinism due to INSR deficiency | KG + DL |
| 17 | disorder of carbohydrate absorption and transport | KG + DL |
| 18 | systemic mastocytosis | KG + DL |
| 19 | hyperinsulinism due to glucokinase deficiency | KG + DL |
| 20 | precocious puberty | KG + DL |
| 21 | osteoarthritis | KG + DL |
| 22 | diazoxide-resistant hyperinsulinism | KG + DL |
| 23 | adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia | KG + DL |
| 24 | pseudoachondroplasia | KG + DL |
| 25 | autosomal dominant hyperinsulinism due to SUR1 deficiency | KG + DL |
| 26 | familial male-limited precocious puberty | KG + DL |
| 27 | gastrin secretion abnormality | KG + DL |
| 28 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 29 | familial hyperinsulinism | KG + DL |
| 30 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 31 | centra precocious puberty 1 | KG + DL |
| 32 | esophageal varices without bleeding | KG + DL |
| 33 | esophageal varices with bleeding | KG + DL |
| 34 | brachyolmia | KG + DL |
| 35 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 36 | myosclerosis | KG + DL |
| 37 | osteoarthritis susceptibility | KG + DL |
| 38 | monosomy X | KG + DL |
| 39 | abnormality of glucagon secretion | KG + DL |
| 40 | pseudopelade of Brocq | KG + DL |
| 41 | 16q24.1 microdeletion syndrome | KG + DL |
| 42 | primary interstitial lung disease specific to childhood | KG + DL |
| 43 | exercise-induced hyperinsulinism | KG + DL |
| 44 | nephrogenic diabetes insipidus | KG + DL |
| 45 | isolated pulmonary capillaritis | KG + DL |
| 46 | arthropathy | KG + DL |
| 47 | congenital pulmonary lymphangiectasia | KG + DL |
| 48 | insulin autoimmune syndrome | KG + DL |
| 49 | polycystic kidney disease 3 with or without polycystic liver disease | KG + DL |
| 50 | varicose disease | KG + DL |
(Showing top 50 of 82 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.